# US 2025/0152637 A1 · Akkermansia for preventing and/or treating reward dysregulation disorders

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0152637 A1
- Document ID: US20250152637A1
- Status: Published application
- Kind: A1
- Application number: 18/838,757
- Filed: 2023-02-22
- Published: 2025-05-15
- Earliest claimed: 2022-02-22
- Assignees: Université Catholique De Louvain
- Applicants: Universite Catholique De Louvain
- Inventors: Amandine EVERARD; Patrice CANI; Alice DE WOUTERS D'OPLINTER; Sabrina HUWART
- Web page: https://patentgrep.com/patent/US20250152637A1

## CPC

- A61K 35/74: Bacteria (therapeutic use of a bacterial protein A61K38/00)
- A61K 35/741: Probiotics (probiotic yeast, e.g. saccharomyces A61K36/06)
- A61K 35/742: Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
- A61P 3/04: Anorexiants; Antiobesity agents
- A61P 25/00: Drugs for disorders of the nervous system
- A61P 25/28: for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A61P 25/30: for treating abuse or dependence
- A61K 2035/115: {Probiotics}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

A composition, which includes one or more bacteria from the genus Akkermansia and/or extracts thereof and/or fragments thereof, for use in the method of preventing and/or treating reward dysregulation disorders. The reward dysregulation disorders include mental disorders, neurological disorders, disorders due to side effects of a treatment and combinations thereof.

## Claims

### Claim at position 1

1-15. (canceled)

### Claim 16

A method of preventing and/or treating reward dysregulation disorders; comprising administering, to a subject in need thereof, a composition comprising one or more bacteria from the genus Akkermansia and/or extracts and/or fragments thereof.

### Claim 17 (depends on 16)

The method according to claim 16, wherein said bacterium is Akkermansia muciniphila or Akkermansia spp. and combinations thereof.

### Claim 18 (depends on 16)

The method according to claim 16, wherein said reward dysregulation disorder is selected from a group consisting of mental disorders, neurological disorders, disorders due to side effects of a treatment and combinations thereof.

### Claim 19 (depends on 18)

The method according to claim 18, wherein said reward dysregulation disorder is a mental disorder selected from a group consisting of addiction-related disorder, eating-related disorder, affective disorders, obsessive compulsive disorders, schizophrenia, attention deficit hyperactivity disorders (ADHD), autism spectrum disorder, anxiety disorder, and the like.

### Claim 20 (depends on 19)

The method according to claim 19, wherein said reward dysregulation disorder is an addiction-related disorder selected from a group consisting of alcohol-related addiction, drug-related addiction, game-related addiction, and the like.

### Claim 21 (depends on 18)

The method according to claim 18, wherein said reward dysregulation disorder is a neurological disorder selected from a group consisting of Parkinson's disease, Tourette Syndrome, and the like.

### Claim 22 (depends on 18)

The method according to claim 18, wherein said reward dysregulation disorder is a disorder due to side effects of a treatment is selected from a group consisting of game-addiction, shopping-addiction, eating-addiction such as hyperphagia, hypersexuality, and the like.

### Claim 23 (depends on 19)

The method according to claim 19, wherein said reward dysregulation disorder is an eating disorder is selected from a group consisting of bulimia nervosa, binge eating disorder, anorexia nervosa including restricting type and Binge-eating/purging type, pica, rumination disorder, purging disorder, night eating syndrome, avoidant restrictive food intake disorder, overweight-related disorder and obesity-related disorders, food addiction, eating addiction, food craving, food seeking, compulsive eating disorders, impulsive eating disorders, unsuccessful caloric restriction diet, non-responders to weight loss or non-responding to dietary intervention for losing weight, and the like.

### Claim 24 (depends on 16)

The method according to claim 16, wherein said composition further comprises one or more active agent(s).

### Claim 25 (depends on 24)

The method according to claim 24, wherein said active agent is a therapeutic agent or a nutritional agent.

### Claim 26 (depends on 24)

The method according to claim 24, wherein said active agent is a beneficial microbe selected from a group consisting of bacteria from the family Verrucomicrobia, from the family Tannerellaceae, from the family Clostridiaceae, from the family Peptostreptococcaceae, from the family Prevotellaceae, from the family Methylobacteriaceae, from the genus Parabacteroides, from the genus Turicibacter, from the genus Coprococcus, from the genus Knoellia, from the genus Prevotella, from the genus Staphylococcus, and the like.

### Claim 27 (depends on 16)

The method according to claim 16, wherein said composition is in the form of a pharmaceutical composition further comprising a pharmaceutically acceptable carrier.

### Claim 28 (depends on 16)

The method according to claim 16, wherein said composition is in the form of a nutritional composition further comprising a nutritionally acceptable carrier.

### Claim 29

A method for adjuvanting a treatment administered to a subject suffering from a reward dysregulation disorder, comprising administering, to a subject in need thereof, a composition comprising one or more bacteria from the genus Akkermansia and/or extracts and/or fragments thereof.

### Claim 30 (depends on 16)

The method according to claim 16, wherein said composition is comprised in a kit, which further comprises means to administer said composition.

### Claim 31 (depends on 29)

The method according to claim 29, wherein said composition is comprised in a kit, which further comprises means to administer said composition.
